Lifecore Biomedical (LFCR) EBIAT: 2009-2025
Historic EBIAT for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -$1.1 million.
- Lifecore Biomedical's EBIAT rose 83.81% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 480.29%. This contributed to the annual value of -$38.7 million for FY2025, which is 422.29% down from last year.
- Per Lifecore Biomedical's latest filing, its EBIAT stood at -$1.1 million for Q2 2025, which was up 92.23% from -$14.8 million recorded in Q1 2025.
- In the past 5 years, Lifecore Biomedical's EBIAT ranged from a high of $15.6 million in Q1 2024 and a low of -$38.5 million during Q4 2021.
- In the last 3 years, Lifecore Biomedical's EBIAT had a median value of -$9.8 million in 2023 and averaged -$10.2 million.
- Within the past 5 years, the most significant YoY rise in Lifecore Biomedical's EBIAT was 211.21% (2023), while the steepest drop was 919.23% (2023).
- Over the past 5 years, Lifecore Biomedical's EBIAT (Quarterly) stood at -$38.5 million in 2021, then skyrocketed by 66.71% to -$12.8 million in 2022, then soared by 211.21% to $14.2 million in 2023, then tumbled by 146.14% to -$6.6 million in 2024, then spiked by 83.81% to -$1.1 million in 2025.
- Its EBIAT stands at -$1.1 million for Q2 2025, versus -$14.8 million for Q1 2025 and -$6.6 million for Q4 2024.